Therapeutic Vaccines Market To Experience Significant Growth During The Forecast Period 2016-2022

The market was valued at USD 11 billion in 2017 and is projected to reach USD 51 billion by 2022, at a CAGR of 29% during the forecast period. The increasing prevalence of chronic diseases such as cancer and HIV/AIDS are the major reasons driving the market growth. These medicines helps to strengthen the immune response of the body against specific diseases. However every medicine need to be approved by FDA. Increasing cases of chronic diseases and need for effective treatment is acting as key driver for this market. Various pharmaceutical companies are working to develop novel vaccines for diseases such as lung cancer, breast cancer, Alzheimer, etc. However, these vaccine developments are in pipeline and yet to be commercialized.

Download free Sample of This Strategic Report:

Market Dynamics
Some of the factors that are propelling the growth of the market arethe favorable funding for R&D, increasing investments by companies, and rise in the prevalence of chronic diseases are. However, high costs of the vaccines and stringent regulatory guidelines are turning out to be hurdles for this market. Provenge and Oncophage are the two approved cancer therapeutic vaccines on the market. A large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period.

Market Segmentation
The market can be segmented by type and geography.
Segmentation by Type –
Auto Immune Diseases Vaccines
Neurological Disease Vaccines
Cancer Vaccines
Infectious Diseases Vaccines
The cancer vaccines sub-segment contributes the highest share in the market.

Segmentation by Geography –
North America
Latin America
The Middle East and Africa

North America has the largest market size, followed by Europe.Rising population and large investments in the field of research and development are few of the reasons for the advancement of the market in Asia-Pacific.

Segmentation by technologies:
Autologous vaccines
Allogeneic vaccines

Key Players
The Key players in the therapeutic vaccines market are:
Bavarian Nordic, Dendreon Corp, GlaxoSmithKline, Pfizer,Cytos Biotechnology, Merck Serono, Novartis, Celtic Pharmaand Transgene

Report ContentsRegional AnalysisReport Highlights
Market segments
Market Drivers, Restraints and Opportunities
Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market – Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players

North America
US and Canada

Latin America
Mexico, Brazil, Argentina and Rest of Latin America

Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe

Eastern Europe
Rest of Eastern Europe

Request For Full Report:

Asia Pacific
Australia and New Zealand
Rest of Asia Pacific

Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa

About Us

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation.

Contact Us

Kenneth Research
Phone:+1 313 462 0609


Leonard Thomas is an energetic and versatile freelance writer for 5 years, he pen down any type of articles and web content. he is a Cambridge University Business English Certificate (Europe Level) holder . he is analytical, enthusiastic and ingenious, with the essence to work variously, strives to emerge as a lucrative individual who has a grasp on market. Congenial Interpersonal skills and the competence to grab every single trivia with foolproof analysis is something he primarily posses .

Leave a Reply